Endospan announced today that Artivion completed its $175 million acquisition of the company, following FDA approval for its Nexus system. The FDA granted premarket approval (PMA) for the Nexus aortic arch system last month. Nexus treats aortic arch disease, including chronic aortic dissections, in patients at high risk for open surgical repair. … [Read more...] about Artivion closes $175M acquisition of aortic arch maker Endospan
endospan
Endospan has positive aortic arch stent graft study results
Endospan today announced the presentation of 30-day results from a study evaluating its Nexus aortic arch stent graft system. Results came out of the statistical dissection primary arm from the TRIOMPHE FDA investigational device exemption (IDE) study. Investigators presented findings at the American Association for Thoracic Surgery (AATS) … [Read more...] about Endospan has positive aortic arch stent graft study results
